ISSCR News
Insights Into Dry Eyes Gained from Stem cell-derived Tear Glands
An estimated 5-15% of people have problems with dry eyes, with symptoms including eye redness, stinging, or burning sensation, and eye fatigue. Dry eye disease (DED) occurs when the eyes’ tear glands produce insufficient or poor-quality tears which can be due to allergy or autoimmune disease, hormonal changes, aging, etc. When left untreated, DED can increase the risk of eye infections and abrasion damage to the ocular surface, which may impair vision.
The ISSCR Announces Poster Award Winners from Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind
Four early career scientists were recognized for their outstanding poster presentations at the ISSCR International Symposium held in Cambridge, USA 11-12 December 2025. The awards are sponsored by WiCell.
Non-opioid ‘Pain Sponge’ Therapy Halts Cartilage Degeneration and Relieves Chronic Pain
The announcement was made at the International Society for Stem Cell Research (ISSCR) Symposium Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind
Session Highlight
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on a novel approach to chronic pain management and joint tissue preservation. The data highlights SN101, a first-in-class induced pluripotent stem cell (iPSC)-derived therapy.
The ISSCR Opens Sold-Out Symposium Showcasing Momentum, Innovation, and New Clinical Data in PSC-Derived Cell Therapies
The International Society for Stem Cell Research (ISSCR) today opened its sold-out international symposium, Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind, taking place 11-12 December at the Hyatt Regency Boston Cambridge. The meeting convenes a capacity audience of 360 global experts, alongside an at-capacity roster of biotech and pharma sponsors and exhibitors – underscoring the strength, interest and continued momentum in cell therapy development despite recent industry contraction.
Now Available: Free, On-Demand Course “Applying the ISSCR Standards for Research”
The International Society for Stem Cell Research (ISSCR) and STEMCELL Technologies today announced the launch of Applying the ISSCR Standards for Research, a free, on-demand course designed to help scientists integrate the ISSCR Standards for Human Stem Cell Use in Research into their work. The course provides practical guidance to strengthen rigor, reproducibility, and responsible use of human stem cells across the research pipeline.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .